RNA
Avidity Biosciences Inc.
Company Overview
| Mkt Cap | $6.05B | Price | $69.85 |
| Volume | 11.04M | Change | +0.23% |
| P/E Ratio | -18.8 | Open | $69.73 |
| Revenue | $10.9M | Prev Close | $69.69 |
| Net Income | $-322.3M | 52W Range | $21.51 - $70.51 |
| Div Yield | N/A | Target | $68.32 |
| Overall | 73 | Value | 55 |
| Quality | -- | Technical | 91 |
No chart data available
Stock Overview
Updated DailyAvidity Biosciences Inc. (RNA) is a leading Manufacturing company in the Pharmaceutical Preparation Manufacturing industry, currently trading at $69.85 with a market capitalization of $6.05 billion. The stock is trading near its 52-week highs, indicating strong momentum, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows RNA with a volume of 11.04 million shares. The stock opened up 0.06% from yesterday's close of $69.69. Current analyst estimates project earnings of $-4.36 per share for this year, with next year targeting $-4.84.
RNA demonstrates very strong technical momentum based on technical analysis. The company trades on the NSD exchange and operates alongside industry peers including PTCT, SRPT, FATE, ACOR, CPRX.
Key investment considerations for RNA include strong overall investment metrics. The company offers a dividend yield of NA% and analyst price targets suggest limited upside of -2.2%. The stock shows neutral valuation indicators based on valuation analysis.
Analysis generated on November 3, 2025 at 04:51 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RNA | $69.85 | +0.2% | 11.04M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Avidity Biosciences Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW